Search

everythinglearnresearchcommunity

for

Search:↓

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

miR-195-5p reduces hair growth ability in cells by blocking a specific growth signal.

Hair in mammals likely evolved from glandular structures, not scales.

SGK3 is essential for proper hair growth and health.

Sh-Polypeptide 9 may be better than minoxidil for hair growth and protection against damage.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Finasteride may protect brain and improve behavior in rats with liver failure.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Procyanidin compounds from apples and barley promote hair growth and prevent hair cell death.